Erratum: Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells (Cell Death and Disease (2013) 4 (e641) DOI: 10.1038/cddis.2013.165)